Why I would buy these stellar growth shares in January

I think 2017 was another great year for Australian growth shares.
One of the key highlights was the performance of A2 Milk Company Ltd (ASX: A2M). Its bumper profit result has gone a long way to justifying its shares more than tripling in value this year.
I see no reason why Australian growth shares can’t continue this strong run next year. In light of this, below I have listed two shares which I think can beat the market in 2018:
Aristocrat Leisure Limited (ASX: ALL)
This gaming technology company is far more than meets the eye. Many investors will know of Aristrocrat Leisure as a designer and manufacturer of pokie machines, but that is only part of its business. The main attraction to the company in my opinion is its fast-growing digital segment. Thanks to a series of acquisitions the segment is poised to be its growth engine for the next decade. I’ve been very impressed at the recurring revenues the segment has generated and expect further strong growth in FY 2018.
CSL Limited (ASX: CSL)
While I wouldn’t necessarily expect this biotherapeutics company’s shares to perform as strongly as they did this year, I still believe they have the potential to outperform the market in 2018 and beyond due to the strong performance of its leading immunoglobulin business and soon to be profitable Seqirus vaccine business. Ultimately, I believe these businesses and the strong underlying demand it is experiencing has put the company in a position to deliver above-average long-term profit growth.
Lastly, here's another opportunity not to be missed out on in 2018.
Bill Gates' Prediction Will Give You Goosebumps
Bill Gates is sounding the alarm on what could be a trillion-dollar technology
And when Bill Gates speaks, it pays to listen.
The huge trend is already starting to take off. Click here to learn more today.
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.